INTRODUCTION
Recognition and binding between cells are of fundamental importance for proper functions of multicellular organisms, both during embryonic development and in the adult stage. Celladhesion molecules (CAMs) are a group of cell-surface glycoproteins with functions related to cell recognition (Edelman & Thiery, 1985) . A cell-surface molecule involved in intercellular adhesion between rat hepatocytes in vitro was first identified by monitoring the ability of papain-solubilized plasma-membrane components to neutralize the inhibition of cell aggregation caused by antibodies directed against the cell surface (Ocklind & Obrink, 1982) . Using this assay, Ocklind & Obrink (1982) purified this aggregation-responsible protein from rat liver plasma membrane. This molecule, which was designated cell-CAM 105, is an integral plasma-membrane glycoprotein with an apparent Mr of 105 000. Hixson et al. (1985) later established by two-dimensional gel analysis that cell-CAM105 is composed of a pair of acidic glycoproteins with isoelectric points of 4.1 and 4.3. In examining the changes in normal cell-surface protein expression in hepatomas, Hixson et al. (1985) observed that there was an apparent loss ofcell-CAM 105 on the cell surface of hepatocellular carcinoma lines examined. Antibodies against purified cell-CAM105, which strongly inhibited re-aggregation of normal hepatocytes, displayed no reactivity in immunoprecipitation assay with hepatocellular carcinoma cells McEntire et al., 1989) . These observations suggest that expression of cell-CAM 105 is altered during the development of the malignant phenotype of hepatocytes.
We have found that the biochemical properties of the cell-CAM105 and the localization of the cell-CAM105 in the liver membranes are verv similar to those previously described for ecto-ATPase (Lin, 1989) . The ecto-ATPase is a plasma-membrane nucleotidase with its nucleotide-hydrolysing site localized on the outside of the cell surface (Lin & Russell, 1988; Lin, 1989; Lin & Guidotti, 1989) . The characteristics of this ecto-ATPase include its activation to a similar extent by either Ca2+ or Mg2+ and its ability to hydrolyse non-specifically several different nucleotides. The ecto-ATPase was purified from rat liver plasma membrane (Lin & Fain, 1984; Lin, 1989) , and antibodies against the protein were prepared. The (von Heijne, 1983) , and the other is near the Cterminus. The structural arrangement predicts that most of the protein mass is on the outside of the cell and that the C-terminus of the protein is intracellular. In the extracellular domain, there are two stretches of sequences similar to the consensus sequences for the nucleotide-binding domains of other nucleotide-binding proteins (Lin & Guidotti, 1989 
Preparation of antibodies
Polyclonal antibodies 669 and 708, which were against purified rat liver ecto-ATPase, were prepared as described previously (Lin, 1989) . Anti-peptide antibodies were prepared by injecting rabbits with peptides coupled to keyhole-limpet haemocyanin as described in Lin (1989) . Anti-N anti-peptide antibody was prepared against a peptide sequence derived from the N-terminal portion of the ecto-ATPase, i.e. SVLLLAHNLPQEFQVC (amino acid positions 50-64 of the ecto-ATPase). Anti-Cl, anti-C2 and anti-C3 antibodies were prepared against peptide sequences within the C-terminal portion of the ecto-ATPase. Anti-Cl is against peptide sequence CDLTEHKPSTSSHNLGP (amino acid positions 460-475), anti-C2 is against peptide sequence CDSPNKVDDVSYSVLNFNAQ (amino acid positions 478-496) and anti-C3 is against peptide sequence CQSKRPTSASSSPTETVYSWKKK (amino acid positions 497-519). Monoclonal antibodies mAb 362.50 and mAb 5.4 were prepared as described in . Rabbit antibody against cell-CAM105, anti-gplO5-2, was prepared as described in (1977) . Procedures for immunoprecipitation analysis of radiolabelled antigens were described in Hixson et al. (1983) . Comparison of the reactivity of two different antibodies was determined by immunodepletion analysis as described in Hixson et al. (1983) . One-dimensional SDS/PAGE was performed as described by Laemmli (1970 One-dimensional maps of peptides generated by digestion with Staphylococcus aureus V8 proteinase were prepared by the method of Cleveland et al. (1982) .
Expression of recombinant ecto-ATPase in COS cells
Expression plasmid cdm8 (Seed, 1987) was obtained from T. Maniatis (Harvard University, Cambridge, MA, U.S.A.). Plasmid containing the full-length ecto-ATPase cDNA was constructed as described by Lin & Guidotti (1989) . COS-M6 cells were transfected with 25 ,ug of plasmid DNA per 100 mm plate by electroporation in a Cell-Porator (Bethesda Research Laboratory, Bethesda, MD, U.S.A.). In brief, COS-M6 cells (2 x 106/ml) were suspended in Hepes-buffered saline containing 21 mM-Hepes (pH 7.05), 137 mM-NaCl, 5 mm-KCl, 0.7 mMNa2HPO and 6 mM-glucose. For electroporation, COS-M6 cells in a volume of 0.5 ml were placed in the electroporation chamber, and the electroporation was performed at 250 V at 330 ,F. After electroporation, the cells were removed from the electroporation chamber and placed in 10 ml of Dulbecco's minimum essential medium (GIBCO, Gaithersburg, MD, U.S.A.) containing 10 % fetal-calf serum. After incubation for 48 h, the culture medium was aspirated and the cells were scraped off dishes with a rubber 'policeman'. The cells were disrupted by mixing with 0.5 ml of distilled water followed by freezing and thawing to obtain total cell lysate.
Other procedures
The liver ecto-ATPase was purified according to the procedures described by Lin & Fain (1984) with modifications as described in Lin (1989) . Western immunoblotting was performed as described in Lin (1989) . Protein concentrations were determined by the micro BCA method according to the procedures described by the manufacturer (Pierce Chemical Co., Rockford, IL, U.S.A.), with BSA as a standard.
RESULTS

Identification of the cell-CAM105 as the ecto-ATPase
Immunological identity. To test the identity of the ecto-ATPase against that of the cell-CAM105, Western immunoblots were performed on the purified ecto-ATPase with monoclonal antibodies against cell-CAM 105 (mAb 362.50 and mAb 5.4) McEntire et al., 1989) . As shown in Fig. 1 (lanes 1 and 1'), both monoclonal antibodies cross-reacted with the purified ecto-ATPase. We have previously reported that the purified ecto-ATPase has different mobilities in SDS/PAGE depending on whether the sample is heated or not (Lin, 1989) . The apparent Mr was in the region of 85 000 if the sample was not heated before being loaded on to the gel. The apparent Mr of the protein changed to around 100000 if the sample was heated before being loaded on to the gel. As shown in Fig. 1 , monoclonal antibodies against cell-CAM105 also recognized a protein with mobility shifts similar to those of the ecto-ATPase (lanes 2 and 3, lanes 2' and 3'). The weak reactivity of mAb 362.50 with the reduced form of ecto-ATPase may be due to the conformational dependence of antibody recognition, since we have observed that an anti-peptide antibody against the N-terminal sequence of the ecto-ATPase (anti-N) (Lin & Guidotti, 1989) identical with that of the cell-CAM 105 immunoprecipitated with mAb 362.50 (Fig. 2) . Two-dimensional gel-electrophoretic analysis showed cell-CAM105 to be composed of a pair of acidic glycoproteins different in pl (4.1 versus 4.3) and in apparent Mr (i.e. 110000 versus 105000) McEntire et al., 1989) . One-dimensional peptide maps of fragments produced with V8-proteinase digestion indicated that these acidic glycoproteins were closely related in structure . Two-dimensional PAGE showed that both antisera 708 and 669
were reactive with high-M, and low-Mr forms (results not shown).
That these two components were identical with cell-CAM 105 was confirmed by the ability of the two antisera to deplete the solubilized cell lysates of both forms reactive with mAb 362.50 (Fig. 3) . In addition, both forms that were reactive with antiserum 669 were depleted by anti-gplO5-2, an antiserum against cell-CAM 105 that has previously been shown to block re-aggregation of isolated hepatocytes (results not shown).
Sequence-specific anti-peptide antibodies. Anti-peptide antibodies against sequences derived from ecto-ATPase cDNA (anti-N, anti-Cl, anti-C2 and anti-C3) were prepared. Anti-N antibody was generated against a peptide sequence derived from the Nterminus of ecto-ATPase, and anti-Cl, anti-C2 and anti-C3 antibodies were generated against three different C-terminal peptide sequences. In the two-dimensional gel, antibodies against the three C-terminal peptides were reactive with only the higher-M, form of cell-CAM 105, which is also recognized by mAb 362.50 (Fig. 4) . On the other hand, antibodies raised against an N-terminal peptide (anti-N) immunoprecipitated both the higher-M, and lower-Mr forms (Fig. 4) , albeit less efficiently (approx. 10 %) than mAb 362.50. This lower efficiency of anti-N most probably resulted from the low affinity of this antiserum for the non-reduced form of the protein. These results together suggest that at least one of the differences between the higher-M, and lower-Mr forms lies in the C-terminal portion of the proteins. Furthermore, all four antipeptide antibodies against peptides derived from N-terminal and C-terminal portions of the ectoATPase immunoprecipitated cell-CAM105. This result indicates that these sequences are present in cell-CAM105.
Vol. 278 sequence information of the ecto-ATPase cDNA clone). The peptide maps of mAb 362.50 and 669 immunoprecipitates were essentially identical (results not shown). There was also identity between the maps of the high-M, forms immunoprecipitated with mAb 362.50 and anti-Cl antisera (results not shown).
Protein expressed from the ecto-ATPase cDNA. To demonstrate that the ecto-ATPase cDNA codes for a protein identical with cell-CAM 105, COS cells were transfected by electroporation with ecto-ATPase cDNA in expression vector cdm8. As shown in Fig. 5 , transfected COS cells expressed a protein that is specifically recognized by both antiserum 708 and mAb 362.50. These results establish unequivocally that the cDNA clone for the liver ectoATPase codes for a protein identical with cell-CAM105. COS cells were transfected with the ecto-ATPase cDNA as described in the Experimental section. The total cell lysate from each sample was used for SDS/PAGE analysis. All the samples were boiled in SDS sample buffer containing 2-mercaptoethanol (Laemmli, 1970 Peptide mapping. To provide additional evidence of the structural identity of cell-CAM105 with the ecto-ATPase, V8-proteinase-digest peptide maps were prepared from the following proteins: (a) the higher-M, and lower-Mr forms of cell-CAM105 immunoprecipitated with mAb 362.50 (which has been shown to be specific for cell-CAM105); (b) the higher-Mr and lower-Mr components immunoprecipitated from whole extracts with antibody 669 (which can precipitate the ecto-ATPase); (c) the higherMr form immunoprecipitated with anti-Cl antiserum (which was prepared against the C-terminal peptide derived from the DISCUSSION This paper reports the immunological and structural identity between the ecto-ATPase cloned by Lin & Guidotti (1989) and rat liver cell-CAM 105. Evidence supporting this identity includes: (1) cross-reactivity of two monoclonal antibodies against cell-CAM 105 with purified ecto-ATPase, (2) ability of antibodies against ecto-ATPase to deplete proteins recognized by the anticell-CAM105 antibodies, (3) In addition, we have shown the presence of at least two isoforms of cell-CAM105/ecto-ATPase: a long form that has a complete C-terminal domain as described in the published ectoATPase sequence and a short form that lacks reactivity with all three C-terminal antipeptide antibodies. This short form, however, still reacts with anti-peptide antibodies generated against an N-terminal peptide and all monoclonal and polyclonal antibodies generated against cell-CAM 105 or ecto-ATPase. These results support an overall structural homology between these two forms. On the basis of the intensities of the iodinated proteins, the relative abundance of these two forms in rat hepatocytes is about 30 % and 70 % for long form and short form respectively.
The identity of cell-CAM 105 and ecto-ATPase was also reported by Aurivillius et al. (1990) . In their studies they obtained five peptide sequences from cell-CAM 105 purified by anti-cell-CAM 105 antibody affinity column chromatography. Four out of these five peptides were found in the ecto-ATPase sequence. Two of these peptides were also found in mouse mmCGM2 (Turbide et al., 1991) and thus could not distinguish between ecto-ATPase and rat CEA-related proteins. Two of the five sequences, however, were unique to ecto-ATPase. Thus their results, obtained by a different approach, agree with our conclusion. The fifth peptide was not found in the sequence of ecto-ATPase, a finding these investigators attributed to the presence of this peptide in the long form of cell-CAM105. On the basis of this conclusion it was speculated that the published sequence must correspond to the short form ofcell-CAM 105, the more abundant of the two forms. Furthermore, they also proposed that alternative splicing may account for the formation of these isoforms. On the basis of the results reported here, several (Williams & Barclay, 1988) , all of which share sequence similarities to each other (Fig. 6) . Although the N-terminal domain does not contain the typical cysteine residues, this domain has characteristics of the immunoglobulin V class (Williams & Barclay, 1988) . Such a sequence feature suggests that the ecto-ATPase/cell-CAM105 is a member of the immunoglobulin superfamily.
Celi-CAM105/ecto-ATPase is highly similar in sequence to CEA The predicted amino acid sequence of the liver ectoATPase/cell-CAM105 is highly similar to that of CEA (Oikawa et al., 1987; Beauchemin et al., 1987) and other related cellsurface glycoproteins, i.e. biliary glycoprotein (BGP1) , non-specific cross-reacting antigen (NCA) and pregnancy-specific ,-I glycoprotein (PSGB1) (Watanabe & Chou, 1988 in the primary sequences of BGP1, PSGB1 and CEA. Therefore it is possible that these proteins also have an ATPase (nucleotidase) activity. The structural similarity between the ectoATPase/cell-CAM 105 and CEA, also a member of the immunoglobulin superfamily, predicts that the ecto-ATPase and CEA may have similar functions. The overproduction of CEA or proteins related to the CEA family is a common cellular phenotypic change in human tumours. This observation has led to the development of immunochemical assays of colon cancers. However, the function and significance of these antigens in malignant transformation are not clear. CEA is a highly glycosylated cell-surface glycoprotein with an Mr of 180000 (the unglycosylated CEA has an Mr of 72800). Consistent with our result, Benchimol et al. (1989) have reported that CEA functions as an intercellular-adhesion molecule.
The similarities in structure and function of cell-CAM105/ecto-ATPase and CEA raise an interesting question concerning their roles during normal cell development and carcinogenesis. Several observations make it likely that the adhesive events mediated by CEA and ecto-ATPase/cell-CAM 105 play vastly different roles during histotypic interactions. In normal tissues, CEA is expressed at highest levels during early fetal development, whereas cell-CAM 105 appears late and shows a major increase at the fetal/neonatal interface (Thompson et al., 1990; Odin & Obrink, 1986 . The major role of cell-CAM 105 was postulated to be in mediating the formation and maturation of the bile canalicular domain (Mowery & Hixson, 1991) . In contrast with CEA, which shows an increased expression in tumours, cell-CAM 105 expression is greatly decreased or disappears on primary hepatocellular carcinomas (Hixson et al., 1985; McEntire et al., 1989; . When considered in the context of fetal/neonatal expression, these differences are consistent with selection for a less differentiated phenotype during carcinogenesis. Alternatively, it is possible that the gene(s) coding for cell-CAM 105/ecto-ATPase have been deleted or inactivated during carcinogenesis, analogously to the deletion of neuronal CAM-like sequences in colorectal cancers (Fearon et al., 1990) .
The association of ATPase activity with cell-CAM 105 raises questions concerning the role of ATPase activity in the regulation of cell adhesion. It is possible that ATP binding and ATP hydrolysis by cell-CAM 105 may contribute to the mechanism of hepatocyte adhesion mediated by this molecule. In this model, hydrolysis ofATP may be directly involved in the conformational change of cell-CAM 105. This conformational change then affects cell adhesion. However, it is also possible that the ATPase activity associated with cell-CAM 105 is unrelated to the molecule's cell-adhesion function.
Ecto-ATPase/cell-CAM105 is composed of a family of isoforms
The cell-CAM 105 was shown to be composed of a pair of acidic glycoproteins that had slight differences in their apparent Mr in SDS/PAGE and in their isoelectric points. These different forms could have resulted from proteolysis during sample preparation, from variations in glycosylation or from expression of different genes. By pulse-chase analysis, we have found no evidence for significant proteolytic conversion and have observed a similar ratio of the higher-Mr to the lower-Mr form in all experiments performed (results not shown). These observations make it unlikely that the lower-Mr form results from random degradation during isolation or immunoprecipitation. There are also no significant differences in glycosylation or phosphorylation that could explain the difference-in isoelectric points and Mr values . In the studies with antibodies against C-terminal peptide sequences, we have found that they only immunoprecipitated the higher-Me form. This result suggests that the major difference between the higher-M, and lower-Mr forms might be in the C-terminal portion of the proteins. Using probes derived from the ecto-ATPase clone to screen a rat liver cDNA library further, we have obtained an additional clone coding for an ecto-ATPase isoform. Besides a cluster of substitutions in the N-terminal domain, this ectoATPase isoform has a shorter C-terminal intracellular domain than that of the previously published sequence (S.-H. Lin, 0. Culic, D. Flanagan & D. C. Hixson, unpublished work) . This information indicates that the two forms of cell-CAM105 observed in the two-dimensional gel-electrophoretic analysis may arise from different gene products.
The presence of an ecto-ATPase activity on the surface of plasma membrane has been observed for many years. Several possible functions for the ecto-ATPase have been proposed (Lin, 1989) but there was no direct evidence. Our studies on the structure of the ecto-ATPase leads to the finding that the liver ecto-ATPase has structural features of the immunoglobulin superfamily and is identical with the rat liver cell-adhesion molecule, cell-CAM 105. Further studies on the relationships between ATPase activity and cell adhesion should be able to provide information on the mechanism and regulation of cell adhesion.
